Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
760 Washburn Ave Ste 201
Corona, CA 92882Phone+1 951-257-8881Fax+1 916-251-0116
Summary
- Jashin J. Wu, M.D., F.A.A.D., is Voluntary Associate Professor at the Department of Dermatology, University of Miami Miller School of Medicine. He is a Councilor for the International Psoriasis Council. He served on the American Academy of Dermatology (AAD)/ National Psoriasis Foundation psoriasis guidelines committee, which published updated 6 psoriasis guidelines in 2019-2021. He is co-editor for 6 textbooks about psoriasis. He is associate editor for the 4th edition of Comprehensive Dermatologic Drug Therapy published in March 2020. He has written over 500 Pubmed articles, of which over 300 are about psoriasis, as well as 70 book chapters. For the AAD, he is Chair of the World Congress Fund Review Task Force. He is Secretary-Treasurer of the Pacific Dermatology Association. Dr. Wu has given over 200 CME lectures at medical conferences and dermatology departments/divisions in 11 countries on 4 continents. He has been awarded 3 Presidential Citations from the AAD (2016, 2021, 2024).
Education & Training
- University of California (Irvine)Residency, Dermatology, 2005 - 2008
- Baylor College of MedicineInternship, Internal Medicine, 2002 - 2003
- Northwestern University The Feinberg School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2004 - 2026
- TX State Medical License 2003 - 2004
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Publications & Presentations
PubMed
- Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study.Steven R Feldman, Ran Gao, Rhonda L Bohn, Stephani Gray, Anouk Déruaz-Luyet
Advances in Therapy. 2025-04-01 - VYJUVEK for Dystrophic Epidermolysis Bullosa: Ethical Dilemmas in Access and Pricing.Rahib K Islam, Andrew J Malek, Kazi N Islam, Rosemary Prejean, Shari R Lipner
Journal of the American Academy of Dermatology. 2025-03-28 - Reduced Major Adverse Cardiovascular Events (MACE) with Interleukin-17 Inhibitors Compared to Methotrexate in Psoriasis Patients: A multi-center retrospective cohort a...Rahib K Islam, Alexander Maltese, Kazi N Islam, Jashin J Wu
Journal of the American Academy of Dermatology. 2025-03-13
Journal Articles
- Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque PsoriasisAndrew Blauvelt, Craig L Leonardi, Jashin J Wu, JAMA Dermatology
- Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis FoundationRonald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA
Authored Content
- Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque PsoriasisApril 2020
Press Mentions
- Dissatisfaction with Multiple Facets of Care Reported in Psoriasis & Psoriatic ArthritisNovember 17th, 2024
- Topical Tapinarof and Roflumilast for Psoriasis: Where Do They Fit In?September 10th, 2024
- How Do Tapinarof and Roflumilast Creams Fit into Psoriasis Treatment?September 5th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: